U.S. federal trademark · Serial No. 99044353 · Reg. No. 1124132
Pharmaceutical preparations for the treatment of metabolic disorders, namely, for treating diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of the endocrine system, namely, for treating growth and thyroid disorders; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, for treating connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, for treating urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of neurological diseases, namely, for use in treating Alzheimer's disease, Huntington's disease, cerebral palsy, brain injuries, spinal cord injuries, and seizure disorders; Pharmaceutical preparations for the treatment of hormonal disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, and thyroid hormone preparations; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, for treating mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology, namely, for use in treating dermatitis, eczema, psoriasis, skin pigmentation diseases, and dermatological sexually transmitted diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.